Biopharmaceutical company developing non-absorbed polymeric drugs for cardiovascular and renal diseases
Biopharmaceutical company developing non-absorbed polymeric drugs for cardiovascular and renal diseases. Its lead product, VELTASSA (patiromer), binds potassium in the gastrointestinal tract to treat hyperkalemia, particularly in patients with chronic kidney disease or heart failure.